KLRA
Kailera Therapeutics Inc.

114
Mkt Cap
$2.97B
Volume
204,725.00
52W High
$28.23
52W Low
$16.00
Price
$22.99
KLRA Fundamentals
Prev Close
$22.94
Open
$23.29
50D MA
$22.69
Beta
0.00
Avg. Volume
1.73M
EPS (Annual)
-$1.76
P/B
-6.88
Rev/Employee
$0.00
Loading...
Loading...

About

Kailera Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its product candidate includes Ribupatide. The company was founded on May 08, 2024 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
145

Frequently Asked Questions

What is Market Cap of Kailera Therapeutics Inc.?
What is the 52-week high for Kailera Therapeutics Inc.?
What is the 52-week low for Kailera Therapeutics Inc.?
What is Kailera Therapeutics Inc. stock price today?
What was Kailera Therapeutics Inc. stock price yesterday?
What is the Price-to-Book ratio of Kailera Therapeutics Inc.?
What is the 50-day moving average of Kailera Therapeutics Inc.?
How many employees does Kailera Therapeutics Inc. have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available